CFGS
VAR

Concourse Financial Group Securities’s Varian Medical Systems, Inc. VAR Stock Holding History

Concourse Financial Group Securities’s Portfolio VAR Stock Details VAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-540
Closed -$95K – 2479
2021
Q1 		$95K Buy
540
+20
+4% +$3.52K 0.01% 960
2020
Q4 		$91K Sell
520
-92
-15% -$16K 0.01% 929
2020
Q3 		$105K Buy
612
+225
+58% +$35.4K 0.01% 765
2020
Q2 		$47K Sell
387
-308
-44% -$35.7K ﹤0.01% 1020
2020
Q1 		$71K Buy
695
+371
+115% +$49K 0.01% 772
2019
Q4 		$46K Buy
324
+127
+64% +$16.2K ﹤0.01% 978
2019
Q3 		$23K Sell
197
-16
-8% -$1.9K 0.01% 921
2019
Q2 		$29K Sell
213
-277
-57% -$37K ﹤0.01% 1093
2019
Q1 		$69K Buy
490
+63
+15% +$8.27K 0.01% 778
2018
Q4 		$48K Buy
427
+255
+148% +$29.2K 0.01% 833
2018
Q3 		$19K Buy
+172
New +$19.5K 0.01% 879

Other funds holding VAR

WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

Concourse Financial Group Securities's VAR Position: Q2 2021 in Review

Concourse Financial Group Securities sold out of Varian Medical Systems, Inc. (VAR) in Q2 2021, closing a stake of 540 shares — an estimated $95K sold.

Concourse Financial Group Securities first reported a position in VAR in Q3 2018 and held it in 11 quarters. The position peaked at $105K in Q3 2020. 1 fund tracked by Wall St. Rank holds VAR as of Q2 2021.

  • Concourse Financial Group Securities reported no remaining Varian Medical Systems, Inc. position as of Q2 2021 after selling out during the quarter.
  • Concourse Financial Group Securities sold 540 Varian Medical Systems, Inc. shares in Q2 2021, an estimated $95K.
  • Concourse Financial Group Securities first reported a position in Varian Medical Systems, Inc. in Q3 2018 and held it in 11 quarters.
  • Concourse Financial Group Securities's Varian Medical Systems, Inc. position peaked at $105K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q2 2021.

Based on Concourse Financial Group Securities's 13F filing for Q2 2021, filed 13 Aug 2021.